The identification of novel biomarkers often involves advanced technologies and large-scale studies. High-throughput sequencing, mass spectrometry, and bioinformatics tools are commonly used. Epidemiologists collaborate with molecular biologists, statisticians, and data scientists to analyze complex datasets and identify potential biomarkers.
